about
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is ...
Read More
88.13
-4.25
(-4.60%)
1.4M
XNAS Volume
XNAS 16 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Abivax (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..